You have no items in your shopping cart.
On Promotion
Category
Tested Applications
WB 42957ELISA 22430SDS-PAGE 15106Blocking 11025IHC 2122MS 2019HPLC 619LF 518CLIA 507EIA 383Cell Culture 288FA 198IP 98IF 88ChIP 57DOT 49IA 38Functional Studies 24FC 21In vitro 15In vivo 14ATPase Activity Assay 9Control 8CBA 6ICC 6Purification 6FACS 2GICA 2IAC 2IB 2ICA 2PCR 2SBR 22D-PAGE 1CoIP 1DARTs Assay 1Double Diffusion 1ELISpot 1FLISA 1HAI 1ID 1IEP 1RIA 1SB 1Turbidimetry 1cDNA Synthesis 1
Reactivity
Human 16893Mouse 6091Rat 4647Monkey 1687Bovine 1675Porcine 1084Canine 675Gallus 657Rabbit 425Virus 392Zebrafish 387Sheep 297Other 56Bacteria 53Hamster 10Goat 9Plant 9Protozoa 9Feline 8Guinea pig 7Parasite 7Equine 5Camelus 3E. coli 3Fungi 2H. pylori 2Primate 2Rat and Mouse 2A. thaliana 1Algae 1Aspergillus 1Ferret 1HCMV 1HSV-1 1Jellyfish 1Marmoset 1Rabies virus 1Yeast 1
Predicted Reactivity
Conjugation
Biologically Active
Featured Product
All Products
Recombinant Human EGFR Protein [orb2994530]Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 69.6 KDa. Observed: 90-120 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg- Recombinant Human IL-17A&17F Protein [orb2994531]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC.(QC verified)
Predicted: 15.1&16 KDa. Observed: 15-25 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Recombinant Human CD40L Protein [orb2994532]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.. SEC-HPLC: Greater than 95% as determined by SEC-HPLC. (QC verified)
Predicted: 16.2 KDa. Observed: 16-18 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Recombinant Human EGFR Isoform vIII Protein [orb2994408]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 39.7 KDa. Observed: 61-75 Kda, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg - Recombinant Mouse SLAMF5 Protein [orb2994409]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.8 KDa. Observed: 35-40 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Recombinant Mouse ALK-1 Protein [orb2994410]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 38.1 KDa. Observed: 55-60 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Recombinant Mouse CHL2 Protein [orb2994411]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 46.2 KDa. Observed: 60-75 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Recombinant Mouse Dtk Protein [orb2994412]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 68.9 KDa. Observed: 90-120 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg - Recombinant Human AMIGO2 Protein [orb2994737]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 67.5 KDa. Observed: 93 KDa, reducing conditions
1 mg, 10 μg, 50 μg, 500 μg - Recombinant Cynomolgus CRTAM Protein [orb2994738]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 57.1 KDa. Observed: 80-90 KDa, reducing conditions
10 μg, 50 μg, 500 μg, 1 mg